S
Shanxi Qianyecao Biotech QYC
Peptide Vendor. Lab-tested. Independently scored.
0.0
0 reviews · Poor
- 9 HPLC samples across 2 products
- Catalog avg purity 69.5%
- Independent testing, no pay-to-rank
Boren Health independently tests products and verifies reviews. Public methodology, no pay-to-rank.
Lab testing results
Independent results across 2 products.
9
Total lab tests
69.5%
Avg purity
100.0%
Best score
35.0%
Worst score
Tested products
| Product | Grade | Tests | Avg | Range | Latest | Price | $/mg |
|---|---|---|---|---|---|---|---|
| Retatrutide | AGREAT | 5 | 79.0% | 66.0% – 100.0% | 11/18/2025 | — | — |
| Tirzepatide | DPOOR | 4 | 60.0% | 35.0% – 78.0% | 10/14/2025 | — | — |
Individual lab tests
Retatrutide7.6
Date
11/18/2025
Purity
99.74%
Quantity
20mg → 19.200mg
Lab
Lab E
Retatrutide8.0
Date
11/17/2025
Purity
99.95%
Quantity
15mg → 14.500mg
Lab
Lab E
Retatrutide7.5
Date
11/14/2025
Purity
99.7%
Quantity
10mg → 10.500mg
Lab
Lab G
Tirzepatide3.5
Date
10/14/2025
Purity
99.4%
Quantity
20mg → 10.800mg
Lab
Lab G
Tirzepatide7.8
Date
10/3/2025
Purity
99.8%
Quantity
30mg → 30.300mg
Lab
Lab E
Retatrutide10.0
Date
8/6/2025
Purity
99.94%
Quantity
20mg → 20.540mg
Lab
Lab F
Tirzepatide7.2
Date
8/5/2025
Purity
99.81%
Quantity
10mg → 9.330mg
Lab
Lab E
| Product | Date | Score | Purity | Quantity | Lab |
|---|---|---|---|---|---|
| Retatrutide | 11/18/2025 | 7.6 | 99.74% | 20mg → 19.200mg | Lab E |
| Retatrutide | 11/17/2025 | 8.0 | 99.95% | 15mg → 14.500mg | Lab E |
| Retatrutide | 11/14/2025 | 7.5 | 99.7% | 10mg → 10.500mg | Lab G |
| Tirzepatide | 10/14/2025 | 3.5 | 99.4% | 20mg → 10.800mg | Lab G |
| Tirzepatide | 10/3/2025 | 7.8 | 99.8% | 30mg → 30.300mg | Lab E |
| Retatrutide | 8/6/2025 | 10.0 | 99.94% | 20mg → 20.540mg | Lab F |
| Tirzepatide | 8/5/2025 | 7.2 | 99.81% | 10mg → 9.330mg | Lab E |
Review summary
Synthesized from reviews · AI
No reviews have been submitted yet for Shanxi Qianyecao Biotech QYC.
About Shanxi Qianyecao Biotech QYC
Peptide VendorContact
All reviews
0.0
0 total
No reviews found matching your criteria.